The FDA recently cleared Spravato® as the first nasal spray for difficult to treat depression, proving high effectiveness when other medications haven’t worked. Spravato® doesn’t…
More than 21 million adults in the United States experienced a major depressive episode in 2021, and over 30% of those people didn’t respond well…
Advancements in mental health care are offering new avenues of hope for people with hard-to-treat depression. Among these are esketamine and ketamine, two powerful tools…
Some people respond well to traditional depression treatments, finding relief with medication quite quickly. However, others still have debilitating symptoms after trying multiple medications, a…